Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Faculty-Student Perceptual Gaps of Curriculum Integration in Problem-Based Learning.

Medical science educator·2026
Same author

Convergent thinking, divergent thinking, and openness to experience as predictors of academic success among high-achieving and typical-achieving medical students.

BMC medical education·2026
Same author

Gene polymorphisms predicting response to hydroxyurea treatment in Bahraini patients with sickle cell disease.

Expert review of hematology·2025
Same author

Psychometric properties of a questionnaire assessing the extent of integration in a problem-based learning curriculum.

BMC medical education·2025
Same author

Evaluation of artificial intelligence-generated drug therapy communication skill competencies in medical education.

British journal of clinical pharmacology·2024
Same author

Artificial intelligence and medical education: application in classroom instruction and student assessment using a pharmacology & therapeutics case study.

BMC medical education·2024

Related Experiment Video

Updated: Jun 25, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Cord blood stem cells.

Khalil E Rajab1, Reginald P Sequeira

  • 1Department of Obstetrics and Gynecology, Arabian Gulf University, Kingdom of Bahrain. yonrajab@batelco.com.bh

Saudi Medical Journal
|February 10, 2009
PubMed
Summary

Stem cells (SCs) from umbilical cord blood offer new therapeutic potential for various diseases and aging. This review examines SC uses, cord blood banking, and the commercialization debate.

Area of Science:

  • Regenerative Medicine
  • Hematology
  • Biotechnology

Background:

  • Umbilical cord blood (CB) offers an alternative source of stem cells (SCs), avoiding ethical concerns associated with embryonic SCs.
  • SC research has expanded, highlighting potential applications in treating diverse conditions.
  • The commercialization of SC banking has grown alongside research interest.

Purpose of the Study:

  • To provide a concise overview of current stem cell applications, with a focus on cord blood.
  • To evaluate the therapeutic potential of stem cells for various diseases and aging.
  • To summarize the ongoing debate surrounding the commercialization of cord blood banking.

Main Methods:

  • Literature review of stem cell research and applications.

More Related Videos

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

  • Analysis of therapeutic targets for stem cell therapy.
  • Examination of the commercial cord blood banking industry and its controversies.
  • Main Results:

    • Stem cells show promise for treating malignant blood diseases, hematological disorders, neurological illnesses, genetic and autoimmune diseases, and skeletal anomalies.
    • Potential applications extend to anti-aging therapies.
    • The commercialization of cord blood banking involves complex claims and counter-claims.

    Conclusions:

    • Umbilical cord blood stem cells represent a significant advancement in regenerative medicine.
    • Further research is needed to fully realize the therapeutic potential of SCs.
    • The commercialization of cord blood banking requires careful consideration of ethical and scientific claims.